Connection

Lauge Østergaard to HIV Infections

Back to Details
This is a "connection" page, showing publications Lauge Østergaard has written about HIV Infections.
Lauge Østergaard
Connection Strength
0.180
HIV Infections
  1. Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):386-393.
    View in: PubMed
    Score: 0.030
  2. Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals. AIDS. 2018 08 24; 32(13):1793-1802.
    View in: PubMed
    Score: 0.030
  3. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin. AIDS. 2018 07 31; 32(12):1729-1731.
    View in: PubMed
    Score: 0.030
  4. Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau. Pan Afr Med J. 2018; 29:18.
    View in: PubMed
    Score: 0.029
  5. Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Jun 15; 64(12):1686-1695.
    View in: PubMed
    Score: 0.028
  6. Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS. 2017 03 27; 31(6):771-779.
    View in: PubMed
    Score: 0.027
  7. Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR. Int J Tuberc Lung Dis. 2017 01 01; 21(1):67-72.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.